Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Nanotechnology therapies can help improve quality of life for those with hair loss.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Older adults often have skin problems due to aging, and treating these conditions requires attention to both physical and mental health.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Certain medicinal plants may help treat alopecia areata by promoting hair growth and reducing inflammation.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Transcutol® helps drugs penetrate the skin more effectively in various formulations.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

New treatments for PCOS focus on managing symptoms and improving fertility.

Combining ultrasound and microneedles improves drug delivery through the skin.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

Athletes need effective management of skin disorders for their performance and well-being.

Biologics for severe asthma have known side effects, but some new risks need more study.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

New methods improve skin disease diagnosis and treatment.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.